Literature DB >> 19107708

Clinical screening of autonomic dysfunction in multiple sclerosis.

Leigh A Hale1, Hitoshi Nukada, Lodewicus J Du Plessis, Karen C Peebles.   

Abstract

BACKGROUND AND
PURPOSE: Multiple sclerosis (MS) can affect the autonomic nervous system. Although exercise may be beneficial for people with MS, those with autonomic dysfunction may have altered heart rate responses to exercise. We investigated the hypothesis that the pattern of increase in heart rate on commencement of a simple cycle test would be different in those participants with MS who had been shown to have autonomic dysfunction on laboratory testing compared with both control participants and MS participants not exhibiting autonomic involvement.
METHOD: A controlled cohort study with a volunteer sample of 31 adults with MS (26 women, 5 men) with a mean age of 46 +/- 8.00 years (32-60 years), a median Expanded Disability Severity Scale of 3 (1-6) and a mean duration since diagnosis of 10.3 years (0.1-39 years). Thirty-one age-matched, non-disabled, sedentary but healthy adults (26 women, 5 men) with a mean age of 45 +/- 9.5 years (24-57) comprised the control group. Autonomic function was evaluated using continuous heart rate and blood pressure responses to rhythmical deep breathing, the Valsalva manoeuvre, passive postural change and a simple cycle test.
RESULTS: There were no significant differences in age, height or weight (p < 0.05) between the two groups or on any of the autonomic test results (p < 0.05). Five participants with MS (16%) had abnormal autonomic function on laboratory testing, two of whom demonstrated an abnormal heart rate response to the cycle test.
CONCLUSIONS: It is suggested that physiotherapists monitor the heart rate response to a dynamic exercise test in people with MS prior to prescribing an exercise programme to ensure patients' safety. Should the response appear delayed or attenuated, referral for more formal autonomic laboratory testing is recommended. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19107708     DOI: 10.1002/pri.416

Source DB:  PubMed          Journal:  Physiother Res Int        ISSN: 1358-2267


  6 in total

Review 1.  Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications.

Authors:  Mario Habek
Journal:  Clin Auton Res       Date:  2019-04-08       Impact factor: 4.435

2.  Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.

Authors:  Simona Petrescu; Raluca Trifanescu; Petru Ionescu; Gina Doinita Vanghelie; Radu Tanasescu; Mircea Moldovan; Nicolae Munjev; Ovidiu Bajenaru; Cristina Panea
Journal:  Maedica (Bucur)       Date:  2013-03

3.  Burn injury and multiple sclerosis: A retrospective case-control study.

Authors:  Matthew R McCann; William F Hill; Jinhui Yan; Sarah Rehou; Marc G Jeschke
Journal:  Burns       Date:  2018-11-23       Impact factor: 2.744

Review 4.  Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis.

Authors:  Martin Langeskov-Christensen; Martin Heine; Gert Kwakkel; Ulrik Dalgas
Journal:  Sports Med       Date:  2015-06       Impact factor: 11.136

5.  Abnormal venous postural control: multiple sclerosis-specific change related to gray matter pathology or age-related neurodegenerative phenomena?

Authors:  Dejan Jakimovski; Matthew Topolski; Kana Kimura; Karen Marr; Sirin Gandhi; Deepa P Ramasamy; Niels Bergsland; Jesper Hagemeier; Bianca Weinstock-Guttman; Robert Zivadinov
Journal:  Clin Auton Res       Date:  2018-08-17       Impact factor: 4.435

Review 6.  Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies.

Authors:  Oliver Findling; Larissa Hauer; Thomas Pezawas; Paulus S Rommer; Walter Struhal; Johann Sellner
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.